Funding will support global launch of US firm's latest laser system for treating atrial fibrillation.
Machine vision firm pays “tens of millions of euros” for Spanish firm; and now represented in all European markets.
French analyst team predicts that market will more than double in value by 2024.
Company also names serial start up leader Adam Kablanian as new CEO.
Value of Neophotonics, Lumentum, and II-VI all slump after blacklisting order by US government.
US firm developing prostheses to restore level of sight to blind people will suspend production of older ‘Argus II’ product.
Yamagata-based Imuzak also develops optical elements based on moth-eye nanostructures.
Revenues, income and margins slide against previous year’s same quarter due to “seasonal softness and aggressive competition” in China.
Continued market weakness in automotive, lighting and mobile devices hits photonics giant, which announces remedial actions.
Sharp increase in sales and bookings from ‘Light and Production’ division keeps German firm on track despite weakness elsewhere.
Overall sales up but photonics segment down amid weak macroeconomic environment and microelectronics slowdown.
First full quarter since Oclaro acquisition, results include impact of restructure and costs related to shift in datacom strategy.